Wednesday, September 30, 2020

Overview of Investment in Barrett Business Services, Inc. (BBSI)

Investment Thesis

Barrett Business Services is a provider of payroll and administrative services as well as professional employment services to small and mid-sized businesses.  It is based in Vancouver WA and has the majority of its current business in the West (CA, OR, UT, WA, CO, ID, AZ, NV, and recently NM) and a smaller base in the East (MD, NC, PA, DE, VA.)  A number of important factors are behind why BBSI is a relatively safe and potentially very good investment in the 1-3 year time horizon.  Growth and multiple expansion are both possible for this small-cap with an excellent balance sheet, solid normalized earnings, and a checkered past. 

As it has done in the recent past, BBSI has plunged in price and is certainly still in value-stock territory at the time of this writing, despite a significant rise from recent lows.  It is an understatement to say that BBSI’s share price has been on a roller-coaster ride over the past 6 years.  Three times over that period it has reached into the high $90’s only to fall back under the cloud of issues that sent the share price plummeting.  Workers' compensation reserve issues, accounting irregularities, and most recently the Covid-19 pandemic provided the drivers for these pullbacks.   The recent low of $27 was reached during the point of maximum market uncertainly in March of 2020.   As was the case for many companies, an entry at that point would have provided an investor with an attractive return even against today’s price in the low $50s.


Although many companies have managed to return to pre-pandemic levels, this write-up explains why I believe an investment in BBSI in the $50-55 range provides an excellent margin of safety and could yield a 3-year annualized return of up to 10-30% not including the current annual dividend yield of 2.25%.

BBSI has been written up multiple times on Seeking Alpha and Value Investors Club.  In most cases, the main theme of these articles has been its low P/E multiple and expected strong recovery due to a solid business model and continued growth.  With such a large number of articles available, I will refer readers to the better of these articles and discuss the support of my investment thesis.  I believe the excellent work by tim321 posted on January 19th, 2018 on VIC (here) provides the clearest and most comprehensive look at BBSI.  Despite the negative return since that publication 2.5 years ago, there is no issue with the premise presented in tim321’s article.  With the exception of potentially rising interest rates, the author’s projections for revenue, EPS, and resulting share price were accurate and actually exceeded by BBSI.

However, the impact of a much-anticipated recession at the end of 2019 followed by the Covid-19 pandemic delivered the stock price a one, two blow that has landed it in value territory once again.  Due to the massive uncertainty surrounding BBSI’s small and mid-sized clients during the global pandemic, BBSI’s share price cratered well ahead of any real drop in revenue or profit forecast.  And although much of the uncertainty of their forecast has been removed, investors cannot be blamed for shying away from a business so closely tied to businesses the size of BBSI’s clients.  This lack of interest in the stock is further explained by the outsized performance of momentum and technology mega-cap companies that have attracted so much money, attention, and produced high returns during the Covid-19 crisis.


Valuation Drivers and Estimates

Augmenting articles posted by others, this posting focuses on the factors that make BBSI a safe, good idea for investors looking for the possibility of excellent returns without sacrifice of the margin of safety.  As with most value plays, however, no immediate rise share price is expected or likely.  A timeframe of 1-3 year will be necessary for BBSI’s value to be realized in the stock price. 

Despite its wild swings in price, BBSI’s current 10-year revenue growth stands at 14%.  Future growth expectations are supported by recent investments in technology and an expansion strategy under the leadership of recently appointed CEO Gary Kramer.  Improvement in the stock price is not solely, or perhaps at all, dependent on this growth.  A full recovery from the pandemic alone should be enough to raise the price to the $80-90 range.   A more detailed review of each of the three catalysts should help to reinforce this idea. 

The three catalysts to drive BBSI’s share price above the current levels include 1.) Leadership changes driving investor confidence, 2.) growth in revenue driven by the expansion of BBSI’s business into new markets, both geographically and client type and 3.) P/E multiple expansion due to restored business at client companies. 

 

o   Leadership Change

The recent retirement of Michael Elich, former BBSI CEO,  is the first major catalyst for change and driver for the expectation of a rising stock price.  While growth under Elich cannot be discounted, other issues surrounding his tenure were destructive to shareholder sentiment.  The most concerning were workers' compensation reserve and inaccurate journal entries by the former CFO that resulted in DOJ and SEC investigations and charges/fines against James Miller, the former CFO, and BBSI as a company.  Miller was said to have benefited substantially by selling stock options that rose in value under the improvements afforded by the fraud that he orchestrated.  While Elich was not charged, the fact that the issues occurred on his watch is cause enough for concern even without a formal accusation or indictment of wrongdoing.  I find it unlikely that such actions occurred completely without his knowledge, if not direct involvement.   

Additionally, claims by employees on review sites such as Indeed and Glassdoor were less than complimentary of Elich.  Such negative claims are often motivated by personal vs. business concerns and require careful review.  However, items focused on the use of company jet, sponsorship of events and the unusually high number of disparaging comments aimed directly at the CEO cannot be ignored; particularly when coupled with the fraud convictions.   Shareholders clearly agreed with this concern as a jump in stock price accompanied the announcement of the retirement and replacement with Gary Kramer. 

Kramer was brought to BBSI from Chubb Limited as CFO to remedy the situation with the reserve and accounting issues in 2016.  And, while it is still early in his tenure as CEO, Kramer has wasted little time in taking steps to make an imprint on the company in a seemingly positive direction.  One such example is a personnel move made shortly after Kramer was appointed.  The elimination of the Chief Strategy Officer position seemed to point to some needed housekeeping (and SG&A reduction) as he took the reins.  Kramer’s approach in his first conference calls and investor the presentation has made a positive impression on me as straightforward and focused on providing stability and growth to BBSI.  Additionally, the recent appointment a legal counsel to the management team should begin to provide a backstop for the concerns that have kept investors at bay in the years following the accounting issues. 

 

o   Growth Plans

Recently, BBSI became eligible to do business in all 50 states.  This action allows BBSI to move away from its West and East bases and into markets that will provide for future, non-organic growth.   

Additionally, BBSI has recently completed an upgrade to their service and data platform called MyBBSI.  This upgrade will reportedly allow expansion of BBSI into PEOs that are more white-collar, professionally based versus the grey or blue-collar clients that they have traditionally served.  Expansion opportunity from this avenue has not been quantified but reduces barriers to entry into other market types.

Kramer has identified growth by acquisition as one of his objectives.  He has explained that a “fit’ with the BBSI’s culture and business model as the key aspects of possible targets.  No specific growth targets have been made public, but sustaining revenue growth consistent with the recent past (absent the Covid-19 pullback) should be achievable.  The growing unrestricted cash reserve provides ample room for a number of smaller acquisitions like the ones discussed by management without the complete sacrifice of their balance sheet strength. 

 

o   Multiple Expansion to Normalized Levels

For a company growing revenue and net income as BBSI has done over the past 9 years, a multiple that is near their all-time low and far below both the market and peers points to recovery once the issues of the pandemic have cleared.  Estimating when that will happen with any level of accuracy is impossible.  In the meantime, BBSI’s stock will likely continue to linger or drift lower with its low TTM and forward P/E multiples.  Investors assuming anything other than a range-bound movement in the price of BBSI stock before significant pandemic clearing has occurred are likely engaging in wishful thinking.  Moreover, ensuring the P/E multiple does not regress after an eventual recovery will depend on BBSI building longer-term confidence with the market that some of their past issues are indeed in the past.  Any hint of accounting or other company/leadership integrity will very likely return BBSI to low multiple status and should be cause to consider exiting any position in the company.    

o   Stock Valuation

To derive a current and future price range for BBSI, we look to it’s current and projected earnings with and without growth.  Below, an expected value for one, two, and three years into the future is then given based on these values.  This approach may appear as imprecise; however, the range is included to illustrate the downside protection that BBSI affords under most market scenarios. 

Revenue growth was assumed at a rather modest 9% for the years of 2022 and 2023 for which no projections are available from analysts.

For EPS values, I use the full range of values used by the 4 analyst that now cover BBSI for the 2020 and 2021 fiscal years.  Further, I assume that some of the existing unrestricted cash on hand is used for acquisitions and a low level of stock buybacks.  In the “Low” side, the acquisitions are assumed to sustain, but not improve revenue.  Only under the worst conditions, below the “Low” estimates would these assumptions not hold.  Net margins are assumed at historical levels under similar revenue levels.

 

 

Risks and Drivers Away from Estimated Value

As with all equity posts, this section should be carefully considered.  These comments are intended to provide a review of the factors which can be expected to cause the share price to diverge to the extremes or beyond the estimates provided. 

In the case of BBSI, the most significant risk to price appreciation is any real or perceived threats to timely and accurate company financial reporting or any other legal issues that might impact the company’s finances.  This is particularly true of any adverse news regarding workers' compensation reserves or risks.  It is no coincidence that the first 4 risk factors listed in the most recent 10K relate to workers' compensation.  Even against growing revenues, profits, and cash reserves,  BBSI’s past issues have hung over the company like a dark cloud.  Institutional and retail investors alike are fully aware of this past and will undoubtedly evaluate any small issue as a sign the company has not reformed. 

Further Downside Risk

Future Failed Acquisition(s) 

In conference calls and investor presentations, BBSI CEO Gary Kramer has pointed to the possibility that an acquisition that would provide entry into a market where BBSI does not currently do business could be one of their growth strategies.  The failure to profitability execute a future transaction of this type could drive the price lower, even if overall company profits are not negatively impacted. 

Competitive Pricing Pressure

BBSI operates in an ever-growing space of outsourced personnel services.  Continuing to maintain a high retention rate among their client base will depend on remaining competitive in that space.  As size and scale become a factor in activities such as payroll processing, it is possible that innovations by larger firms focused on these specific areas may make this segment of BBSI’s business unprofitable or a drag on their model.  It is not possible to quantify just how this would impact BBSI, but currently, reported retention rates may not fully reflect the erosion of this type which might ultimately impact margins.

 

To the Upside

Higher Than Expected Growth

Either organic and/or inorganic growth that exceeds the 9-10% assumptions that are part of the valuation above will almost certainly raise the stock price beyond provided estimates, all other things being equal.  Despite its past troubles, BBSI has seems to handle the scaling of their business model without issue.  This model and recent information platform upgrade should enable continued margin expansion as BBSI increases revenue through increased client counts.  BBSI has expressed interest in entering the more employer-friendly markets of Texas and Florida.  If successful in these markets, growth to the upside could be expected to far outpace projections.

 

Solid and Consistent Financials

BBSI’s recent sale of a portion of their workers compensation liability reinforces the company’s position that their book of claims and reserves are in line with risk profiles of those claims  (see press release here.)  It is my view that the key statement in the release that, The transfer price of the LPT was approximately equal to the book value of the claims liabilities with no material gain or loss on the transaction.”  This substantiates that BBSI’s claims reserves are indeed appropriate and that WC claims are much less likely to impact the company’s performance going forward.   Should BBSI be able to stabilize their earnings coming out of the pandemic and find drivers that would further reduce the cyclicality of their business model, the market would almost certainly assign a higher multiple to the stock.

 

Final Thoughts About BBSI

Clearly, the operating space of small and mid-sized businesses that BBSI serves is counter to a major and growing US trend toward mega-cap company investing bias.  This trend has prevailed since the financial crisis of 2008 as a dominant investment theme.  The underperformance of value and small-cap stocks over that time has been the subject of countless articles and discussions. If this trend continues, it will undoubtedly provide a headwind for BBSI’s clients.  Whether that trend translates into a headwind for the company has yet to be seen and will certainly not help their case. 

By the same token, should that trend reverse course, BBSI’s current value status and small company association will almost certainly be a tailwind for the company.

At this time, investors should consider these macro drivers as tiebreakers, but not necessarily primary considerations for investment in BBSI.  The potential for stabilizing the company, growing their solid business model, and reaping the benefits of returning investor confidence are the primary reasons for investing in BBSI.  As the impacts of the global pandemic subside, BBSI should be well-positioned regardless of these and other macro trends.

Tuesday, September 15, 2020

Overview of Investment in Argan Inc. (AGX)

Investment Thesis

Argan Inc. (AGX) is a holding company that owns four operating units including an engineering, procurement, and construction (EPC) company known as Gemma Power Systems (GPS).  GPS specializes in building natural gas power plants for customers throughout the continental US.  It is Argan’s most significant operating company and the driver of overall financial performance.  Argan also owns three other operating units (The Roberts Company-TRC, Atlantic Projects Company-APC, and SMC Infrastructure Solutions-SMC) that generate revenues and profits that are substantially less than GPS. Argan’s shareholder presentation dated September 2020 (here) provides a clear overview of the structure.

I believe Argan's valuation at the recent prices of $35-40 provides investors the opportunity to benefit from the company's lagging price appreciation and current, historically high project backlog.  Investors with a time horizon of 1-2 years could see their investment grow 30-80% in that same time period with downside protection provided by a growing cash reserve that currently stands at over $25 per share.  

Argan is a small-cap company and GPS's size is significanly smaller than other EPC companies normally associated with powerplant infrastructure.  Despite their size, they have built a healthy niche in the area of natural gas-fired plants with a favorable history of execution on these complex projects.  The result as been the ability to produce large amounts of free cash flow at the high point of this profitable and somewhat cyclical business.  As recently as 2017/2018 Argan's TTM FCF reached levels of $800-900M, mostly on the strength of GPS.

However, in late 2017, a growing concern for a dwindling backlog at GPS sent investors running to the exits, driving the price down to the mid $40's after touching a high of $75 earlier in the year.  While the backlog drought was short-lived, the market did not reward investors with a price rebound as the backlog was restored (to all-time highs.)  Additionally, recent losses at APC on a project in the UK seemed to further push investors away at a time when price recovery would be expected. As a consequence, the share price has remained essentially flat for the past three years as the overall markets have moved higher.


Adding to concerns of backlog and execution at APC is a lack of clarity surrounding the performance at all of Argan's three "other" operating units.  Argan does not hold conference calls or provide much in the way of company promotion.  Very little has been communicated regarding plans to ensure these units contribute positively to overall results.  The lack of communication from management on this topic leaves investors uncertain.  Argan’s most recent 10K (fiscal year ending Jan 31st, 2020) contains language that clearly exhibits concern over the performance of The Roberts Company in the years following its 2015 acquisition. 

"...With the reengagement and leadership of TRC’s founder, our financial support and the substantial completion of these loss contracts, we acquired TRC with the belief that it was positioned to succeed in the future with a return to profitable operations. Significant efforts have been expended since the acquisition to sustain a financial turnaround with growing revenues and profitable operating results. Although actual results for Fiscal 2019 were encouraging, results of operations sagged in Fiscal 2020. There can be no assurances that TRC will re-establish the positive trend in revenues or improve profitability in the future..,"

Unsurprisingly, both TRC and APC recorded impairment charges last year. 

TRC and APC’s poor overall performance and the small size of SMC leave GPS as the operating unit that drives Argan’s performance. Unfortunately, even though GPS generally performs very well, Argan’s SG&A costs have gone up substantially post TRC and APC acquisition. It is clear that Argan must deal with their acquisition issues if longer-term shareholder value is to be increased.  There is a possibility that both APC and TRC will be deemed complete acquisition failures and be dealt with accordingly.  Without resolution of these issues, any future discussion from management about acquisitions would likely be met with scorn from shareholders. 


My Position

AGX is my largest position at approximately 15% of my portfolio. I purchased approximately 1/3 of the position in mid-2018 and the rest in late 2019 and early 2020. With the GPS backlog fully restored to $1.2B (additional projects in the queue totally over $3B that are not all bookable), the downside is well protected absent major execution or contract issues with ongoing or future projects.    

As I am now retired with over 1/2 of my living expenses covered by my IRA, downside protection is a major concern for any investment, particularly ones exceeding 5% of my portfolio. AGX provides this protection with the opportunity for good or very good returns and limited downside exposure due to a cash position that has now reached over $400M.  Evidence for the downside support can be seen in Argan's price in response to the market reaction to the Coronavirus.  While the price briefly touched $32 during the depths of the selloff, the share price has now fully recovered as many other industrial companies lag the market.



Future Outlook 

Analyst estimates for 2021, 2022 and 2023 are $0.65, $4.00+ and $5.00+ respectively. There are only 2 analysts currently covering the company and no public research is available. Assuming GPS performs as it has in the past, the share price is expected to rise as the backlog is converted to cash.  However, investors expecting outsized returns from near-term share price jumps are likely to be disappointed. The factors discussed in the investment thesis, high institutional/insider ownership, and the market’s current assessment of value stocks like AGX are all factors holding the price down even though the current fundamentals and future outlook are positive. 

Value estimates from KORR Acquisitions, a fund that holds a substantial position in the stock, range from $75 to north of $90. KORR has recently been active in pushing management to improve shareholder value. The open letter (here) details their view of where value needs to be created. Based on previous FCF with similar revenue in the past, these estimates seem fair or even a bit conservative. Much will depend on GPS’s ability to maintain or grow their backlog as they complete projects. This will continue to be a key indicator that I will be watching in addition to project execution/margins. 

My personal, conservative estimate of fair value (as of Sept ‘20) is $67-$75. I will consider, but may not necessarily, sell 1/3 to 1/2 of my total position within this range. Depending on the outlook at the time and management’s ability to mitigate the company cyclicality issues and improve performance at APC and TRC, I may either hold on to 2/3 of my current position or possibly sell the entire position. I expect to update this write-up when/if the price climb to the $67-$75 range is realized. 


Risks and Drivers Away from Estimated Value 

As with all EPC companies, many of the major risks involve contract and project execution. Generally, this explains much of their low multiples alongside their inherent cyclical nature. AGX and more specifically GPS has a good reputation within the industry for execution. However, Argan has sited in their 10K that a move toward ever greater numbers of fixed price-contracts continues to increase the risk posed by project execution issues. They contend that this has been the driver of some companies’ choice to exit the business of building power plants. A development that is viewed as positive by Argan. With high institutional and insider ownership and considering the backlog and performance issue discussed, the price action of the stock has been focused on current performance rather then any future prospects.  Additional project starts and subsequent revenue improvement is likely to be the key driver of price improvement. 

To the Downside
Argan’s most recent failure in the area of project execution has been with APC who suffered significant losses at the TessRep Project located in The UK. Schedule delays and cost overruns have resulted in major project losses. Management has reportedly put these issues behind them by realizing all of the losses and converting the remaining contract work to time and material. Additional clarity on this project should come over the next 1-2 quarters as the project is completed. However, a similar experience at any other active projects withing APC or GPS could tank the stock price. AGX reports in their July 30th, 2020 10Q that management changes have taken place at APC in response to the issues and losses.

As already mentioned, a repeat of backlog depletion would be cause for divergence from the expected value of $67-75. As this has already occurred recently, any significant backlog reduction over the period of the next 2-4 quarters, could quickly cause the price to fall back to the mid $30’s or possibly lower. 

Although less likely, margin compression on the current book of projects could cause misses to the EPS estimates that are currently in play. 

Lastly, any near-term discussion from management about acquisition targets or similar discussion would almost certainly send the stock tumbling given their recent lack of integration success. No discernible benefit has come from the 2016 acquisitions and any hint of a repeat would be a cause for many investors to consider exiting the stock (including me.) 

To the Upside
The recent announcement of stock repurchases and a special dividend of $1.00/share suggests that AGX management is aware that they need to be more proactive in the promotion of shareholder value as a driver for the stock price. However, the somewhat modest nature of both of these actions has done little to lift sentiment and price beyond their direct calculated values.

Argan has noted in their 10K that the trend toward natural gas-fired power plants and a reduced number of competitors should favor them in the coming years. If Argan can further their competitive advantage in these facilities while standardizing and reducing the risks, upside to the stock estimate could be achieved. However, the growing trend toward renewables in the developed countries could stem the demand for natural gas-fired power plants should policy in the US, UK, and other countries where Argan does business opt to move more aggressively away from fossil fuels. These two trends may very well be offsetting and causing natural gas-fired plants to still be built, but at a reduced rate and with increased public opposition. 

Another upside advantage could come from improving the operating performance and contributions from both APC and TRC. While I have not studied the acquisition case for these units at length, it is hopeful from their statements concerning performance of both of these companies will be converted into actions to improve their relative contribution. Without the benefit of conference calls to probe such issues, investors are left to filing statements to understand actions for the underperforming units.

Last, is the chance that AGX pursues a sale of GPS or the entire company to a larger firm. KORR has been pushing for this route. But without any comment from management, it is difficult to assess this possibility or the premium that such a move would bring. AGX has been silent on any acquisition or divestiture strategy, but the latter seems counterintuitive to their stated position and perceived actions. The ever-increasing cash and cash equivalents that AGX has on the balance sheet makes the possibility of a deal to gain access to unlock that reserve real, if not somewhat remote. A 15-30% upside to the prevailing price might be expected should such an event occur.

sej, sept 2020

  Update - Pzena Investment Management Inc. (PZN) Review In October of 2020, I provided an overview of my investment in Pzena Investment...